MEI Pharma, Inc. MEIP
3.07 USD 0.00 (+0.00%)
At closeSep 10, 2025, 4:00 PM EDT
2.85 Day range 3.25
2.85 52-week range 3.25
- YTD
- +132.58%
- 1 year
- +132.58%
Revenue & Expenses
Latest period ending Jun 30, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 | FY 2020 Jun 30, 2020 |
|---|---|---|---|---|---|
| 65.30M | 48.82M | 40.70M | 34.80M | 27.76M | |
| 65.30M | 48.82M | 40.70M | 33.39M | 25.09M | |
| 14.54M | -36.76M | -75.48M | -60.42M | -25.70M | |
| 17.78M | -31.84M | -54.45M | -41.31M | -47.17M | |
| 2.67 | -4.78 | -9.99 | -12.00 | -10.40 |
Balance sheet
| Fiscal year | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 | FY 2020 Jun 30, 2020 |
|---|---|---|---|---|---|
| 3.71M | 16.91M | 15.74M | 153.43M | 182.63M | |
| 41.38M | 120.81M | 177.84M | 174.10M | 209.73M | |
| 8.36M | 96.19M | 125.43M | 124.63M | 132.67M | |
| 33.02M | 24.62M | 52.41M | 49.47M | 77.06M |
Cash flow
| Fiscal year | FY 2024 Jun 30, 2024 | FY 2023 Jun 30, 2023 | FY 2022 Jun 30, 2022 | FY 2021 Jun 30, 2021 | FY 2020 Jun 30, 2020 |
|---|---|---|---|---|---|
| -50.47M | -52.48M | -48.75M | -31.96M | 34.26M | |
| 49.14M | 53.69M | 6.89M | 24.71M | -106.29M | |
| -11.87M | -40.00K | 49.05M | 3.47M | 74.78M | |
| -7.00K | -35.00K | -479.00K | -708.00K | -894.00K | |
| -13.20M | 1.17M | 7.20M | -3.79M | 2.74M |